These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 25923442)

  • 1. Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Liu QN; Trudeau MC
    PLoS One; 2015; 10(4):e0123951. PubMed ID: 25923442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant N-terminal domain fully restores deactivation gating in N-truncated and long QT syndrome mutant hERG potassium channels.
    Gustina AS; Trudeau MC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(31):13082-7. PubMed ID: 19651618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.
    Gianulis EC; Trudeau MC
    J Biol Chem; 2011 Jun; 286(25):22160-9. PubMed ID: 21536673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction of eag domains and cyclic nucleotide-binding homology domains regulate deactivation gating in hERG channels.
    Gianulis EC; Liu Q; Trudeau MC
    J Gen Physiol; 2013 Oct; 142(4):351-66. PubMed ID: 24043860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted activation of human ether-à-go-go-related gene channels rescues electrical instability induced by the R56Q+/- long QT syndrome variant.
    Venkateshappa R; Hunter DV; Muralidharan P; Nagalingam RS; Huen G; Faizi S; Luthra S; Lin E; Cheng YM; Hughes J; Khelifi R; Dhunna DP; Johal R; Sergeev V; Shafaattalab S; Julian LM; Poburko DT; Laksman Z; Tibbits GF; Claydon TW
    Cardiovasc Res; 2023 Nov; 119(15):2522-2535. PubMed ID: 37739930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HERG channel (dys)function revealed by dynamic action potential clamp technique.
    Berecki G; Zegers JG; Verkerk AO; Bhuiyan ZA; de Jonge B; Veldkamp MW; Wilders R; van Ginneken AC
    Biophys J; 2005 Jan; 88(1):566-78. PubMed ID: 15475579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
    Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation.
    Chen J; Zou A; Splawski I; Keating MT; Sanguinetti MC
    J Biol Chem; 1999 Apr; 274(15):10113-8. PubMed ID: 10187793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes.
    Mehta A; Sequiera GL; Ramachandra CJ; Sudibyo Y; Chung Y; Sheng J; Wong KY; Tan TH; Wong P; Liew R; Shim W
    Cardiovasc Res; 2014 Jun; 102(3):497-506. PubMed ID: 24623279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT.
    Al Sayed ZR; Pereira C; Le Borgne R; Viaris de Lesegno C; Jouve C; Pénard E; Mallet A; Masurkar N; Loussouarn G; Verbavatz JM; Lamaze C; Trégouët DA; Hulot JS
    Circulation; 2024 Aug; 150(7):563-576. PubMed ID: 38682330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
    Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
    J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hERG potassium channel intrinsic ligand regulates N- and C-terminal interactions and channel closure.
    Codding SJ; Trudeau MC
    J Gen Physiol; 2019 Apr; 151(4):478-488. PubMed ID: 30425124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
    Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
    J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
    Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
    Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hERG1a N-terminal eag domain-containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: a possible mechanism for long QT syndrome.
    Trudeau MC; Leung LM; Roti ER; Robertson GA
    J Gen Physiol; 2011 Dec; 138(6):581-92. PubMed ID: 22124116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of WT and mutant hERG K(+) channels expressed in neonatal mouse cardiomyocytes.
    Lin EC; Holzem KM; Anson BD; Moungey BM; Balijepalli SY; Tester DJ; Ackerman MJ; Delisle BP; Balijepalli RC; January CT
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1842-9. PubMed ID: 20363883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The eag domain regulates hERG channel inactivation gating via a direct interaction.
    Gustina AS; Trudeau MC
    J Gen Physiol; 2013 Feb; 141(2):229-41. PubMed ID: 23319729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two mutations at different positions in the CNBH domain of the hERG channel accelerate deactivation and impair the interaction with the EAG domain.
    Kume S; Shimomura T; Tateyama M; Kubo Y
    J Physiol; 2018 Oct; 596(19):4629-4650. PubMed ID: 30086184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Mechanism of Rosuvastatin-Induced Decrease in Mature hERG Protein Expression on Membrane.
    Feng PF; Zhang B; Zhao L; Fang Q; Liu Y; Wang JN; Xu XQ; Xue H; Li Y; Yan CC; Zhao X; Li BX
    Mol Pharm; 2019 Apr; 16(4):1477-1488. PubMed ID: 30807184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
    Jehle J; Ficker E; Wan X; Deschenes I; Kisselbach J; Wiedmann F; Staudacher I; Schmidt C; Schweizer PA; Becker R; Katus HA; Thomas D
    Br J Pharmacol; 2013 Mar; 168(5):1215-29. PubMed ID: 23061993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.